Industry, Business & Agriculture Timetable

Industry, Business & Agriculture Timetable

Dated 23.10.2020*

THE CONFERENCE WILL BE HELD ACCORDING TO ISRAEL STANDARD TIME (IST UTC +2)

Monday, October  26

12:30-12:45

12:30-12:35
Prof. Raphael Mechoulam
Institute for Drug Research, The Hebrew University of Jerusalem, Israel

12:35-12:40
Mr. Yossi Bornstein
Founder & CEO of Shizim Group; Founder & Partner of Cann10, Israel

12:35-12:40
Mr. Yuli (Yoel) Edelstein
Minister of Health, Israel

12:45-13:30

IF WE CANNOT CHANGE THE FUTURE AT LEAST WE CAN CHANGE OUR ATTITUDE

12:45-13:15
Prof. Dedi Meiri
Assistant Professor, Heads the “Laboratory of Cancer Biology and Cannabinoid Research”, Technion, Israel Institute of Technology, Israel

13:15-13:30
Live Discussion/Q&A

14:00-14:45

MEDICAL GRADE CANNABIS: DEFINITIONS AND CONCEPTS

14:00-14:25
Dr. Raquel Peyraube
Executive Committee, the International Association for Cannabinoid Medicines, Uruguay

14:25-14:40
Live Discussion/Q&A

14:45-15:45

CULTIVATING SCIENCE IN THE MEDICAL CANNABIS BUSINESS

14:45-15:00
EMERGING TECHNOLOGIES FOR TESTING AND ANALYZING MEDICAL CANNABIS COMPOUNDS
Joshua Alper
Chief Strategy Officer, Harvest 360 Technologies, USA

15:00-15:05 – Live Q&A with Joshua Alper

15:05-15:20
TLE: CHANGING THE PERCEPTION OF PLANT-BASED MEDICINE BY USING SCIENCE WITH GREENWAY DNA
Clare Navas
CEO & Founder, The Leaf Extract, Spain

15:20-15:25 Live Q&A with Clare Navas

15:25-15:40
SAVE THE TERPS, ORG CANNABIS FLOWER QUALITY SCORING SYSTEM WITH RESPECT TO TERPENOID CONTENT AND WATER ACTIVITY
Andrew Samann
CEO, Orion GMP Solutions, USA

15:40-15:45 Live Q&A with Andrew Samann

16:30-17:30

PANEL DISCUSSION: WOMEN IN THE FOREFRONT OF CANNABIS INNOVATION

16:30-17:20

Moderator:

Mrs. Ma’ayan Weisberg Joels
CEO, Hiliz, Israel

Panelists:

Mrs. Ma’ayan Weisberg Joels
CEO, Hiliz, Israel

Mrs. Iris Bincovich
CEO, InnoCan Pharma, Israel

Mrs. Yona Cymerman
Co-Founder and COO, Can Innovations, Israel

17:20-17:30
Live Discussion/Q&A

18:00-19:00

CELEBRATION OF PROF. MECHOULAM’S 90TH BIRTHDAY

18:00 – 18:10

Birthday Greetings

Mr. Yossi Bornstein

Founder & CEO of Shizim Group; Founder & Partner of Cann10, Israel

Mr.  Yuli (Yoel) Edelstein

Minister of Health, Israel

Mr. Dan Rivlin

CEO, Kenes Group, Israel

18:10 – 18:20

The Scientist

18:20 – 18:30

A Salute to Prof. Mechoulam’s Outstanding Contribution to Mankind

18:30 – 18:50

Prof. Raphael Mechoulam: Reflections on My Scientific Life – Interview with Dr. Dedi Meiri

Prof. Raphael Mechoulam

Institute for Drug Research, The Hebrew University of Jerusalem, Israel

Prof. Dedi Meiri

Assistant Professor, Heads the “Laboratory of Cancer Biology and Cannabinoid Research”, Technion, Israel Institute of Technology, Israel

18:50 – 19:00

Live Content

Tuesday, October 27

13:45-14:20

MEET THE EXPERTS: CANNABIS PLANT SCIENCE: INTERPLAY BETWEEN CANNABINOIDS AND ENVIRONMENTAL CONDITIONS

13:45-14:10
Dr. Nirit Bernstein
Ph.D., Senior Research Scientist, ARO, Volcani Institute, Israel

14:10-14:20
Live Discussion/Q&A

ABSTRACT PRESENTATIONS I

14:20-14:30
A PILOT RANDOMISED PLACEBO-CONTROLLED TRIAL OF CANNABIDIOL TO REDUCE SEVERE BEHAVIOURAL PROBLEMS IN CHILDREN AND ADOLESCENTS WITH INTELLECTUAL DISABILITY
Asst. Prof. Daryl Efron, Australia

14:30-14:40
CANNABIS GENE VARIATION – COMPARISON OF MULTIPLE GENOME ASSEMBLIES
Dr. Oori Weisshaus, Israel

14:40-14:50
TREATING HIDRADENITIS SUPPURATIVA (HS) WITH CANNABIS
Mrs. Irit Avisar, Israel

14:50-15:00
CANNABINOIDS AND CBD FOR BEAUTY AND SKIN DISORDERS
Dr. Jeanette Jacknin, United States

15:00-15:10
CAUSE OR EFFECT: INCREASED PREVALENCE OF CANNABIS USE IN INFLAMMATORY BOWEL DISEASE SYSTEMATIC REVIEW OF THE EPIDEMIOLOGICAL EVIDENCE
Dr. Gabor Z. Xantus, United Kingdom

15:10-15:20
CANNABIS MODULATION OF INFLAMMATORY SKIN DISEASES
Dr. Yehuda Baruch, Israel

15:20-15:30
CANNABIDIOL IN ACUTE LOW BACK PAIN – A PROTOCOL AND RATIONALE OF A CLINICAL EFFECTIVENESS TRIAL
Asst. Prof., Anna Gyarmathy, United Kingdom

ABSTRACT PRESENTATIONS II

14:20-14:30
NOVEL DEVICE AND FORMULATION FOR CANNABIS INHALER
Dr. Eran Toledo, Israel

14:30-14:40
INVESTMENTS IN STRATEGY AND DATA ARE THE KEY TO SUCCESS IN EUROPEAN MEDICAL CANNABIS
Mr. TJ Unger

14:40-14:50
NOVEL DELIVERY PLATFORMS FOR CANNABIS-BASED THERAPIES
Dr. Oren Levy

14:50-15:00
THE MECHANISM OF ACTION AND MOLECULAR TARGET OF CANNABIDIOL IN HUMAN GLIOMA
Dr. Chao Yan

15:00-15:10
CANNABIS AND ITS MEDICALLY RELEVANT EFFECTS: AN ONLINE GENOMIC STUDY DESIGN
Dr. Nancy Saccone

15:10-15:20
MEDICAL CANNABIS AS A THERAPEUTIC RESOURCE: PRELIMINARY STUDY
Dr. Mariano Velazquez

15:20-15:30
TBA

15:30-16:30

THE INTERPLAY OF SCIENCE, BUSINESS AND LAW

14:00-14:15
BUSINESS OPPORTUNITIES WITH NEW REGULATIONS IN LATIN AMERICA: THE BRAZILIAN CASE
Alessandra Mourao
Founder, Nascimento e Mourão Advogados, Brazil

14:15-14:20 – Live Q&A with Alessandra Mourao

14:20-14:35
ENGINEERING AND PATENTING LEGAL CANNABIS
Dr. Joseph Mogan
President, Kotzker Consulting, Llc, USA

14:35-14:40 – Live Q&A with Joseph Mogan

14:40-15:00
THE ROAD TO GAP AND GMP ACCREDITATION – PRACTICAL LESSONS LEARNT, AND THE CHALLENGES OF OPERATING FROM A REMOTE LOCATION
Francois Ferreira
CEO, MG Health, Lesotho

14:55 – 15:00 – Live Q&A with Francois Ferreira

17:00-17:45

WORKSHOP: CANNABIS EXTRACTION AND PURIFICATION METHODS: YOU NEED TO FOCUS IN COMPLIANCE AND THE FINAL PRODUCT REQUIRED

17:00-17:35
Dr. Xavier Nadal
Ph.D., Director, EthnoPhytoTech Research & Consulting, Spain

17:35-17:45
Live Discussion/Q&A

17:45-18:45

INTEGRATING SCIENCE AND BUSINESS: A BRAZILIAN PERSPECTIVE

16:45-17:15
AN OVERVIEW ON CANNABINOID MEDICINE
Dr. David Bearman
MD, University of Wisconsin and University of Washington School of Medicine, USA

17:15-17:35
CONTRIBUTIONS OF CANNABIS COMPANIES TO SCIENCE AND MEDICAL EDUCATION IN BRAZIL
Mr. Gabriel Barbosa
MSc in Biotechnology, R&D and Regulatory Supervisor, HempMeds, Brazil

17:35-17:45
Live Discussion/Q&A

Chair: Mrs. Caroline Heinz
Co-CEO, HempMeds, Brazil

Wednesday, October  28

15:30-16:30

ROUND TABLE DISCUSSION: MEDICAL CANNABIS AND THE ROLE OF PHARMACISTS: THE ISRAELI EXPERIENCE

15:30-16:20
Chair: Mrs. Yael Meir
Chief Operating Officer, Cann 10 – Medical Cannabis, Israel

Mr. David Papo
Chair of the Israeli Pharmaceutical Society, Israel

Mr. Liron Goldstein
Telepharma, Israel

16:20-16:30
Live Discussion/Q&A

16:45-17:30

MEET THE EXPERTS: CLINICAL STUDIES AND MEDICAL CANNABIS

Dr. Stephen Levenstein
M.D., VP, Clinical Trials Division, GCP Clinical Studies, Israel

Dr. Hanna Billig
Ph.D., Manager, Drugs Clinical Trials Unit, Israeli MOH, Israel

Dr. Yael Zenziper Straichman
Ph.D., Manager of the Research & Development Unit, IMCA, Israel

17:30-18:45

TOWARDS THE INTEGRATION OF CANNABIS INTO MEDICINE IN THE 21ST CENTURY

17:30-17:50
TUNING THE ENDOCANNABINOID SYSTEM: WHEN TREATMENT MATCHES THE PATIENT
Dr. Fabricio Pamplona
Head of Science – CSO, Proprium Health Technology and Science, Brazil

17:50-18:10
SELECTION AND DOMESTICATION OF CANNABIS STRAINS AS A BASIS FOR MEDICINE DEVELOPMENTS
Prof. Hinanit Koltai
Senior Research Scientist, Agricultural Research Organization, Volcani Center, Israel

18:10-18:30
TOPICAL CANNABIS-BASED MEDICINES (TCBM): A NOVEL PARADIGM FOR INTEGUMENTARY & WOUND MANAGEMENT
Dr. Vincent Maida
Associate Professor, University of Toronto, Canada

18:30-18:45
Live Discussion/ Q&A

* could be subject to change